Back to trial details

Intake questionnaire

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Applying to Northwestern University · Evanston, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 18 and 75 years old?
2. Have you been diagnosed with Moderately to Severely Active Crohn Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Evanston for study visits?